Nanalysis Scientific Corp (NSCI : TSX-V)
Common Stock
$0.14
CAD
-0.00 (-1.82%)
Last updated: 2026-06-25
NSCI
Nanalysis Scientific Corp
Performance
1 Day
-1.82%
1 Week
+12.50%
1 Month
-3.57%
YTD
-25.00%
Key Statistics
Market Cap
$16.61M
52W High
$0.25
52W Low
$0.11
P/E Ratio
-
50 Day MA
$0.14
200 Day MA
$0.16
Beta
0.09
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 6/25/2026 | $0.14 | $0.14 | $0.14 | $0.14 | $0.14 | 15,553 |
| 6/24/2026 | $0.13 | $0.14 | $0.13 | $0.14 | $0.14 | 291,665 |
| 6/23/2026 | $0.11 | $0.12 | $0.11 | $0.12 | $0.12 | 16,100 |
| 6/22/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 10,023 |
| 6/19/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 0 |
| 6/18/2026 | $0.12 | $0.12 | $0.12 | $0.12 | $0.12 | 55,501 |
| 6/17/2026 | $0.11 | $0.12 | $0.11 | $0.12 | $0.12 | 217,339 |
| 6/16/2026 | $0.13 | $0.13 | $0.12 | $0.12 | $0.12 | 71,186 |
| 6/15/2026 | $0.13 | $0.13 | $0.12 | $0.13 | $0.13 | 80,711 |
| 6/12/2026 | $0.13 | $0.13 | $0.13 | $0.13 | $0.13 | 0 |
Analyst Price Targets
Based on analyst covering NSCI
Wall Street analysts forecast NSCI stock price to rise 270.4% over the next 12 months.
Consensus
No RatingAvg. Target
C$0.50
+270.4% Upside
Current Price
C$0.14
Last close
Analyst ratings and price targets are updated periodically. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on NSCI's historical volatility
30-Day Vol
61.5%
Annualized
90-Day Vol
70.8%
Annualized
Trend (90d)
-15.3%
Annualized drift
90d Mean
C$0.13
Expected price
| Horizon | Expected | 68% Range (1ฯ) |
|---|---|---|
| 30 trading days | C$0.13 | C$0.11 โ C$0.16 |
| 60 trading days | C$0.13 | C$0.10 โ C$0.18 |
| 90 trading days | C$0.13 | C$0.09 โ C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯ, 95% band = ยฑ2ฯ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Nanalysis Scientific Corp
Nanalysis Scientific Corp. develops, manufactures, and sells magnetic resonance technology products in Canada, the United States, Europe, Asia, and internationally. The company operates through the Scientific Equipment and Security Services segment. It offers nuclear magnetic resonance (NMR) spectrometers; magnetic resonance test, and measurement and diagnostic system; a 60-NMR platform; 100-NMR platform; 60-TEACH; QUAD NMR Console; and the Cameleon 4 console, a compact alternative to facilitate MRI for teaching. The company also provides software products, such as NMRGui, a user interface for data acquisition and processing of benchtop NMR products; SPINit MR software platform to facilitate data acquisition, processing, and pulse programming; and NMRFx platform that offers a suite of software tools to streamline and automate MR data analysis and management. In addition, it offers security services, including preventive and on-call maintenance services, scheduled preventative maintenance work, corrective maintenance work, installation and upgrade projects for detection and general security equipment; other technical maintenance services; and installation and maintenance services for commercial security equipment, such as scanning devices, metal detectors, detection equipment, and other general security equipment. It serves pharmaceutical, biotechnology, nutraceutical, education, chemical, security, food, oil and gas, materials, life science, medical, and educational industries. Nanalysis Scientific Corp. is headquartered in Calgary, Canada.
Financials
- Revenue (TTM)
- $40.20M
- EBITDA
- $-3.70M
- Profit Margin
- -14.01%
- ROE (TTM)
- -41.44%
- EPS (Diluted)
- -0.05
- Book Value
- 0.09
Classification
- Sector
- Information Technology
- Industry
- Electronic Equipment, Instruments & Components
- Group
- Technology Hardware & Equipment
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE Report